Research
September 9, 2021
UAMS Research Team Finds Potential Cause of COVID-19 ‘Long-haulers’
LITTLE ROCK — A UAMS research team has identified a potential cause of long-lasting symptoms experienced by COVID-19 patients, often referred to as long-haulers. The findings were published in the journal, The Public Library of Science ONE (PLOS ONE). At the heart of the team’s findings is an antibody that shows up weeks after an…
August 25, 2021
NIH Awards UAMS’ Nakagawa $3.6 Million to Expand HPV Cancer Vaccine Study
Mayumi Nakagawa, M.D., Ph.D., was awarded $3.6 million from the National Cancer Institute (NCI) to complete phase 2 clinical trials of PepCan, a breakthrough vaccine she developed at UAMS to treat cancers caused by human papillomavirus (HPV).
August 23, 2021
UAMS Researchers Awarded $2.5 Million Grant to Create Phone App to Prevent Opioid Use Relapse
LITTLE ROCK — A team of UAMS research scientists has been awarded a five-year grant worth $2.5 million from the National Institute on Drug Abuse to determine if a cell phone application can reduce the relapse rate in people with opioid use disorder.
August 19, 2021
UAMS Researcher Leading $3.1 Million Preschool Intervention to Reduce Obesity and Cancer in Arkansas, Louisiana
UAMS is leading a major new effort to reduce cancer by addressing eating habits in early childcare and education settings. The project, led by UAMS’ Taren Swindle, Ph.D., will reach about 5,000 children and 500 teachers across Arkansas and Louisiana.
July 28, 2021
UAMS Research Looks at Arkansans’ Preferred COVID-19 Testing Sites, Reasons for Not Getting Tested
FAYETTEVILLE – Two studies by researchers at the University of Arkansas for Medical Sciences (UAMS) have shed some light on Arkansans’ preferred locations for COVID-19 testing and the reasons why some people may decide not to get a test in the first place. “Due to the recent surge in COVID-19 cases and hospitalizations in Arkansas,…
July 21, 2021
Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team
LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…
July 20, 2021
UAMS Releases Findings from Statewide COVID-19 Antibody Study
LITTLE ROCK — A statewide COVID-19 antibody study led by UAMS found that by the end of 2020, 7.4% of Arkansans had antibodies to the virus, but there were wide disparities among racial and ethnic groups. UAMS researchers released their findings this week to a public database, medRxiv (med archive).
July 14, 2021
NIH Awards $1.36 million Grant to Aid UAMS Research on Pregnant Women’s Pelvic Floor Muscles
The National Institutes of Health has awarded a $1.36 million grant to researchers at UAMS to develop a non-invasive means of detecting weaknesses in a pregnant woman’s pelvic floor muscles that could lead to injury while giving birth.
July 9, 2021
UAMS Medical Student Published in JAMA Network Open
The Journal of the American Medical Association (JAMA) recently published University of Arkansas for Medical Sciences (UAMS) medical student Austin Morgan’s results from his study on diversity among cancer centers’ leadership.
July 7, 2021
Researcher Finds Challenges in Study Involving Methamphetamine
If the photo of the pile of crystal methamphetamine doesn’t get your attention, the question on the flyer, designed by the UAMS Translational Research Institute and complete with the UAMS logo and familiar triangles, will.
“Use meth?”
Previous page Next page